It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...
A new study from the Yale School of Public Health (YSPH) offers fresh insights into our understanding of colorectal cancer ...
It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...